Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $0 | reported | |
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2016 | 2016-12-31 | $0 | reported | |
| FY 2015 | 2015-04-30 | $49,286 | reported | |
| FY 2014 | 2014-04-30 | $158,926 | reported | |
| FY 2013 | 2013-04-30 | $1,190,928 | reported | |
| FY 2012 | 2012-04-30 | $363,781 | reported | |
| FY 2011 | 2011-04-30 | $103,167 | reported |
Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR
Twelve months to Sep 30, 2026 · derived
Tenax Therapeutics, Inc. is the 306th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
Latest filing Nov 16, 2026
The us-gaap concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
105 managers · Quarter ended Sep 30, 2026All holders ›
31